Synthetic pathway optimization for improved 1,2,4-butanetriol production

Area of Science:

• Biotechnology
• Metabolic Engineering
• Synthetic Biology

Background:

• 1,2,4-Butanetriol (BT) is a non-natural chemical with significant industrial applications.
• Improving the efficiency of BT biosynthesis is crucial for its wider adoption.
• Identifying and addressing bottlenecks in BT production pathways is essential for process optimization.

Purpose of the Study:

• To construct a prototype strain for 1,2,4-butanetriol (BT) production.
• To identify and alleviate bottlenecks in the BT biosynthetic pathway.
• To optimize BT production through systematic strain and condition engineering.

Main Methods:

• Engineered Escherichia coli BW25113 by assembling a four-step synthetic pathway for BT production.
• Disrupted competing xylose metabolic pathways in the host strain.
• Performed systematic fine-tuning of pathway enzyme expression levels.
• Optimized production conditions including temperature, pH, and cell density.

Main Results:

• Achieved a 4.3-fold increase in BT production compared to the prototype strain.
• Attained a final titer of 1.58 g/L of 1,2,4-butanetriol.
• Reached a yield of 7.9% after 72-hour biotransformation.
• Identified key bottlenecks and optimized expression for enhanced BT biosynthesis.

Conclusions:

• Systematic optimization of enzyme expression and fermentation conditions significantly enhances 1,2,4-butanetriol production.
• The developed engineered strain and optimized process represent a substantial improvement in BT biosynthesis efficiency.
• This work provides a foundation for further scale-up and industrial application of bio-based 1,2,4-butanetriol.